- Home
- ALZN vs XAIR Comparison
ALZN vs XAIR Comparison
Compare ALZN & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALZN | XAIR |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 5.4M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALZN | XAIR |
|---|---|---|
| Price | $1.32 | $6.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $10.00 |
| AVG Volume (30 Days) | 133.1K | ★ 234.9K |
| Earning Date | 03-11-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.99 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,679,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 107.26 |
| 52 Week Low | $0.84 | $0.33 |
| 52 Week High | $3.14 | $8.19 |
Technical Indicators
Market Signals| Indicator | ALZN | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 63.15 | 77.17 |
| Support Level | $1.04 | $0.64 |
| Resistance Level | $2.25 | $8.19 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | 0.01 | 0.49 |
| Stochastic Oscillator | 89.69 | 71.07 |
Price Performance
Historical ComparisonAbout ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.